Feb. 13 at 5:45 PM
$CMBM
You likely won’t hear much from the company until the re-audits and updated financial statements are completed. The compliance deadline set by the Nasdaq Hearings Panel is April 16, and management has publicly indicated they expect to meet that requirement.
The situation remains tightly coiled. If there is materially positive news—particularly confirmation of compliance and filings becoming current—it would not likely translate into a minor price reaction given the elevated short interest and days-to-cover dynamic. You may see another week long run.
That said, our thesis has never been short-term driven. The focus remains on the next 12 months and beyond, where operational execution and restored reporting compliance should matter far more than week-to-week volatility. Still expecting close to
$10 late fall.
